drugset / Trial / NCT03542422
Apatinib as First -Line Treatment for Advanced Esophagus Cancer
NaSingle-groupOpen-labelTreatment
Summary
An Exploratory study of Amapinib for patients with advanced esophagus cancer .
Timeline
- Start
- 2018-06-30
- Primary completion
- 2018-12
- Completion
- 2019-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |